Several studies have associated Ki-67 expression with the effectiveness of chemotherapy in GC [48,49], as previously shown in a study where high expression of Ki-67 was associated with shorter disease-free survival and overall survival in GC patients who received neoadjuvant FLOT chemotherapy [49]. This evidence concerns the gene MKI67 and gastric cancer.